Back
Protara Therapeutics Stock Price Chart
DeFi Coin Triggers All "Buy" Signals And Could Break Out Soon
Discover our top DeFi pick for potentially massive gains now (before it's too late).
Sell
29
TARA
Protara Therapeutics
Last Price:
2.97
Seasonality Move:
-6.44%
7 Day Trial
ALL ACCESS PASS
$
7
$50 trade to make today with huge potential!
Click here to access my #1 options strategy for overnight wins starting with $50!- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TARA is experiencing slight buying pressure.
Protara Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.94 | Buy |
| 20-day SMA: | 3.12 | Sell |
| 50-day SMA: | 3.68 | Sell |
| 200-day SMA: | 2.41 | Buy |
| 8-day EMA: | 2.98 | Sell |
| 20-day EMA: | 3.14 | Sell |
| 50-day EMA: | 3.27 | Sell |
| 200-day EMA: | 2.82 | Buy |
Protara Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.19 | Sell |
| Relative Strength Index (14 RSI): | 43.38 | Sell |
| Chaikin Money Flow: | 10431 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.79 - 3.83) | Sell |
| Bollinger Bands (100): | (2.04 - 3.88) | Buy |
Protara Therapeutics Technical Analysis
| Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Protara Therapeutics Stock
Is Protara Therapeutics Stock a Buy?
- Protara Therapeutics share price is 2.98 while TARA 8-day simple moving average is 2.94, which is a Buy signal.
- The stock price of TARA is 2.98 while Protara Therapeutics 20-day SMA is 3.12, which makes it a Sell.
- Protara Therapeutics 50-day simple moving average is 3.68 while TARA share price is 2.98, making it a Sell technically.
- TARA stock price is 2.98 and Protara Therapeutics 200-day simple moving average is 2.41, creating a Buy signal.
TARA Technical Analysis vs Fundamental Analysis
Sell
29
Protara Therapeutics (TARA)
is a Sell
Is Protara Therapeutics a Buy or a Sell?
-
Protara Therapeutics stock is rated a Sell
The current Protara Therapeutics [TARA] share price is $2.98. The Score for TARA is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
Protara Therapeutics Stock Info
Market Cap:
34.07M
Price in USD:
2.98
Share Volume:
278.74K
Protara Therapeutics 52-Week Range
52-Week High:
5.24
52-Week Low:
1.04
Sell
29
Protara Therapeutics (TARA)
is a Sell
Protara Therapeutics Share Price Forecast
-
What is the Protara Therapeutics stock price today?
The Protara Therapeutics stock price is 2.98 USD today. -
Will TARA stock go up or go down?
Protara Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Protara Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Protara Therapeutics is overvalued.
Is Protara Therapeutics Stock a Buy?
- Protara Therapeutics share price is 2.98 while TARA 8-day exponential moving average is 2.98, which is a Sell signal.
- The stock price of TARA is 2.98 while Protara Therapeutics 20-day EMA is 3.14, which makes it a Sell.
- Protara Therapeutics 50-day exponential moving average is 3.27 while TARA share price is 2.98, making it a Sell technically.
- TARA stock price is 2.98 and Protara Therapeutics 200-day simple moving average is 2.82, creating a Buy signal.
Fundamental Analysis of Protara Therapeutics
Is Protara Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.06 per share, and a decrease next year of $0.50 per share.
Technical Analysis of Protara Therapeutics
Should I short Protara Therapeutics stock?
- TARA Moving Average Covergence Divergence (MACD) indicator is -0.19, suggesting Protara Therapeutics is a Sell
- Protara Therapeutics Relative Strength Index (RSI) is 43.38, which suggest Protara Therapeutics is oversold
- The Bollinger Bands (25) for Protara Therapeutics is (2.79 - 3.83), which suggest Protara Therapeutics is a Buy
- The Bollinger Bands (100) for Protara Therapeutics is (2.04 - 3.88), which suggest Protara Therapeutics is a Buy
* Protara Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.